1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow PI3Kbeta Inhibitor AZD8186: new trials by email Literature Review of PI3Kbeta Inhibitor AZD8186 trials Research Report on PI3Kbeta Inhibitor AZD8186
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery Docetaxel, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 23 | 2018-09-24 | 2026-04-29 |
Breast Neoplasms (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
National Cancer Institute (NCI) (1)
United States (1)
Alison M Schram (1)
UM1CA186691 (1)